MedImmune has formed a partnership with the National Cancer Institute to develop cancer therapies that use the immune system or attack tumor cells to fight the disease.
{iframe}http://www.baltimoresun.com/business/bs-bz-medimmune-nci-20150121-story.html{/iframe}